Galvanize Therapeutics
Therapeutic DevicesWebsite
Galvanize Therapeutics valuation and funding history | Last updated: July 7, 2025 | 2 funding rounds
Current Valuation
N/A
As of July 7, 2025
Total Funding Raised
$206.1M
Across 2 rounds
Last Round
Later Stage VC
$100.0M
Last Funding
Jul 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| July 7, 2025 | Later Stage VC (Series C) | $100.0M | N/A | - |
| March 29, 2022 | Later Stage VC (Series B) | $100.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Galvanize Therapeutics is currently valued at N/A as of July 7, 2025. The company has raised a total of $206.1M in funding across 2 funding rounds.
Explore More Data
Detailed analysis for Galvanize Therapeutics
What is Galvanize Therapeutics Worth in 2026?
Galvanize Therapeutics is a leading private company in the Therapeutic Devices sector. Track Galvanize Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Galvanize Therapeutics Valuation is Determined
Private company valuations like Galvanize Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.